Apart from being the ideal time for relaxing, travelling and organizing children's camps, summer time also presents an opportunity to gain the kind of valuable knowledge that you will not find in school, not read in a high school textbook, nor are you ever going to hear it on TV. On June 22, researchers from the Institute of Bioorganic Chemistry (IBCh RAS) shared such knowledge during Biology Day, a popular science event that was organized at the Institute of Bioorganic Chemistry. This is the second time that such an event is taking place, at the initiative of the Council of Young Scientists.


  • Russian Scientists have detected unusual behavior of the PIWIL2 gene “helpers” science news VII.15

    A team of scientists from the Institute of Bioorganic Chemistry RAS have discovered new information on how the PIWIL2 human gene expresses itself. This breakthrough discovery shall help create a diagnostic marker for determining testicular germ cell tumors. The research findings suggest the interchangeability of the PIWIL2 “helpers”: the promoter of this gene is also able to act as an enhancer of the expression of another gene. The work, published in the PLoS ONE journal, helps expand the background knowledge in this field.

  • How research into glowing fungi could lead to trees lighting our streets (The Guardian) science news VII.8

    On a moonless night deep in a Brazilian rainforest the only thing you are likely to see are the tiny smears of light from flitting fireflies or the ghostly glow of mushrooms scattered around the forest floor. Both effects are the result of bioluminescence, the peculiar ability of some organisms to behave like living night-lights. (this text was pblished in The Guardian)

  • Lynx1 protein competes with the amyloid peptide science news VII.4

    A joint study on the Lynx1 protein that was conducted by researchers from the Institute of Bioorganic Chemistry of the Russian Academy of Sciences together with their colleagues from the universities of Copenhagen and Leipzig, has revealed that this protein competes with human nicotinic acetylcholine receptors for binding to amyloids, which are the main cause for the development of Alzheimer's disease. In the future, the protein could be used in the development of new treatment therapies or future combinations for the treatment of disease. The results of the experiment were published in the Neurobiology of Aging journal.